TARGETED INHIBITION OF KINASES IN CANCER THERAPY

gan Baker, Stacey J., Reddy, E. Premkumar
Cyhoeddwyd 2010

CDK4: A Key Player in the Cell Cycle, Development, and Cancer

gan Baker, Stacey J., Reddy, E. Premkumar
Cyhoeddwyd 2012

Understanding the temporal sequence of genetic events that lead to prostate cancer progression and metastasis

gan Baker, Stacey J., Reddy, E. Premkumar
Cyhoeddwyd 2013

p89c-Myb is not required for fetal or adult hematopoiesis

gan Baker, Stacey J., Kumar, Atul, Reddy, E. Premkumar
Cyhoeddwyd 2010

Molecular Mechanisms Associated with the Regulation of Apoptosis by the Two Alternatively Spliced Products of c-Myb

gan Kumar, Atul, Baker, Stacey J., Lee, Clement M., Reddy, E. Premkumar
Cyhoeddwyd 2003

JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies

gan Jatiani, Shashidhar S., Baker, Stacey J., Silverman, Lewis R., Reddy, E. Premkumar
Cyhoeddwyd 2010

Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia

gan Baker, Stacey J., Cosenza, Stephen C., Ramana Reddy, M.V., Premkumar Reddy, E.
Cyhoeddwyd yn Oncotarget (2019)

A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance

gan Gumireddy, Kiranmai, Baker, Stacey J., Cosenza, Stephen C., John, Premila, Kang, Anthony D., Robell, Kimberly A., Reddy, M. V. Ramana, Reddy, E. Premkumar
Cyhoeddwyd 2005

B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development

gan Baker, Stacey J., Ma’ayan, Avi, Lieu, Yen K., John, Premila, Reddy, M. V. Ramana, Chen, Edward Y., Duan, Qiaonan, Snoeck, Hans-Willem, Reddy, E. Premkumar
Cyhoeddwyd 2014

Dual Inhibition of CDK4/Rb and PI3K/AKT/mTOR Pathways by ON123300 Induces Synthetic Lethality in Mantle Cell Lymphomas

gan Divakar, Saikrishna A., Reddy, M.V. Ramana, Cosenza, Stephen C., Baker, Stacey J., Perumal, Deepak, Antonelli, Anthony C., Brody, Joshua, Akula, Balaiah, Parekh, Samir, Reddy, E. Premkumar
Cyhoeddwyd yn Leukemia (2015)

Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblast...

gan Padgaonkar, Amol, Rechkoblit, Olga, Vasquez-Del Carpio, Rodgrigo, Pallela, Venkat, Venkata Subbaiah, DRC, Cosenza, Stephen C., Baker, Stacey J., Ramana Reddy, M.V., Aggarwal, Aneel, Reddy, E. Premkumar
Cyhoeddwyd yn Oncotarget (2018)

A Non–ATP-Competitive Dual Inhibitor of JAK2(V617F) and BCR-ABL(T315I) Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition

gan Jatiani, Shashidhar S., Cosenza, Stephen C., Reddy, M.V. Ramana, Ha, Ji Hee, Baker, Stacey J., Samanta, Ajoy K., Olnes, Matthew J., Pfannes, Loretta, Sloand, Elaine M., Arlinghaus, Ralph B., Reddy, E. Premkumar
Cyhoeddwyd 2010

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a Potent Inhibitor of Cyclin-Dependent Kinas...

gan Reddy, M. V. Ramana, Akula, Balireddy, Cosenza, Stephen C., Athuluridivakar, Saikrishna, Mallireddigari, Muralidhar R., Pallela, Venkat R., Billa, Vinay K., Subbaiah, D. R. C. Venkata, Bharathi, E. Vijaya, Vasquez-Del Carpio, Rodrigo, Padgaonkar, Amol, Baker, Stacey J., Reddy, E. Premkumar
Cyhoeddwyd 2014

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

gan Athuluri-Divakar, Sai Krishna, Carpio, Rodrigo Vasquez-Del, Dutta, Kaushik, Baker, Stacey J., Cosenza, Stephen C., Basu, Indranil, Gupta, Yogesh K., Reddy, M.V. Ramana, Ueno, Lynn, Hart, Jonathan R., Vogt, Peter K., Mulholland, David, Guha, Chandan, Aggarwal, Aneel K., Reddy, E. Premkumar
Cyhoeddwyd yn Cell (2016)